# Cochrane

# Trusted evidence.

# Informed decisions.

# Library

# Better health.

# Analysis 1.5. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 5: Induction of clinical remission in UC at longest follow-up: subgroup analysis by type of donor

# Cochrane Database of Systematic Reviews

|Study or Subgroup|FMT Events|FMT Total|Control Events|Control Total|Weight|Risk Ratio M-H, Random, 95% CI|Risk Ratio M-H, Random, 95% CI|
|---|---|---|---|---|---|---|---|
|1.5.1 Single donor|12|23|8|22|15.3%|1.43 [0.73 , 2.82]| |
|Březina 2021|12|23|8|22|15.3%|1.43 [0.73 , 2.82]| |
|Crothers 2021|2|7|0|8|2.3%|5.63 [0.31 , 100.52]| |
|Fang 2021|9|10|5|10|15.7%|1.80 [0.94 , 3.46]| |
|Haifer 2022|8|15|3|20|9.5%|3.56 [1.13 , 11.18]| |
|Pai 2021 (1)|4|13|4|12|9.5%|0.92 [0.29 , 2.89]| |
|Sarbagili Shabat 2022|6|36|6|15|11.5%|0.42 [0.16 , 1.09]| |
|Subtotal (95% CI)|41|104|26|87|63.8%|1.37 [0.76 , 2.48]| |

Total events: 41 / 26

Heterogeneity: Tau² = 0.27; Chi² = 10.66, df = 5 (P = 0.06); I² = 53%

Test for overall effect: Z = 1.04 (P = 0.30)

|Study or Subgroup|FMT Events|FMT Total|Control Events|Control Total|Weight|Risk Ratio M-H, Random, 95% CI|Risk Ratio M-H, Random, 95% CI|
|---|---|---|---|---|---|---|---|
|1.5.2 Multiple donors|12|38|3|35|9.2%|3.68 [1.13 , 11.98]| |
|Costello 2019|12|38|3|35|9.2%|3.68 [1.13 , 11.98]| |
|Moayyedi 2015|9|38|2|37|6.9%|4.38 [1.01 , 18.94]| |
|Paramsothy 2017|11|41|3|40|9.0%|3.58 [1.08 , 11.88]| |
|Rossen 2015|7|23|5|25|11.1%|1.52 [0.56 , 4.13]| |
|Subtotal (95% CI)|39|140|13|137|36.2%|2.77 [1.54 , 4.98]| |

Total events: 39 / 13

Heterogeneity: Tau² = 0.00; Chi² = 2.22, df = 3 (P = 0.53); I² = 0%

Test for overall effect: Z = 3.39 (P = 0.0007)

|Total (95% CI)|FMT Total|Control Total|Weight|Risk Ratio M-H, Random, 95% CI|
|---|---|---|---|---|
| |244|224|100.0%|1.79 [1.13 , 2.84]|

Total events: 80 / 39

Heterogeneity: Tau² = 0.24; Chi² = 17.15, df = 9 (P = 0.05); I² = 48%

Test for overall effect: Z = 2.47 (P = 0.01)

Test for subgroup differences: Chi² = 2.72, df = 1 (P = 0.10), I² = 63.3%

# Footnotes

(1) Stool samples from multiple donors not pooled, but a participant received samples from different donors at different times.

# Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.